Central administration of palmitoylethanolamide decreases hyperalgesia in mice via inhibition of NF‐κB nuclear signalling in dorsal root ganglia. Eur J Pharmacol All 3 experiments are consistent with present literature on PEA’s substantial therapeutic index, which makes it a fascinating prospect for the 1st line therapy of joint soreness. In https://josueztlaq.blogsidea.com/36721500/facts-about-palmitoylethanolamide-revealed